Table 1

Background of gastric cancer patients with serum TFF3 analysis
Parameters Cases (n) Serum TFF3 (ng/ml) P
Age
 ≤60 44 12.72 ± 1.21 0.0529
 >60 46 20.29 ± 3.59
Gender
 Male 75 16.65 ± 2.28 0.9489
 Female 15 16.31 ± 2.90
Site
 Fundus/Cardia 35 13.96 ± 1.18
 Gastric body 22 20.28 ± 7.43 0.323
 Antrum 30 16.92 ± 1.69
Degree of differentiation
 Well-moderately 41 13.10 ± 1.27 0.1034
 Poorly 49 19.51 ± 3.40
Stage (I-III VS IV) 0.0017
 I 9 8.89 ± 1.35
 II 9 12.94 ± 2.24
 III 29 12.07 ± 0.73
 IV 43 22.02 ± 3.89
Lymphatic metastasis
 N(-) 13 10.71 ± 1.01 0.3057
 N(+) 33 12.23 ± 0.83
  N1 12 12.91 ± 1.81
  N2 7 11.84 ± 1.98 0.9603
  N3 4 11.85 ± 0.82
Distant metastasis
 M0 48 11.97 ± 0.76 0.0108
 M1 42 21.88 ± 3.97

Xiao et al.

Xiao et al. BMC Clinical Pathology 2014 14:26   doi:10.1186/1472-6890-14-26

Open Data